text:
Archived News
From the New York Times to the Wall Street Journal to USA Today to dozens of newspapers and journals around the country, Impresa research gets read. Here's a sampling of recent articles highlighting our work.
Top articles:
Cities Race to Bet on Biotech, Despite Long Odds, New York Times
Downturn Hurts Expectations in Portland, New York Times
Energy Costs Accelerating Return to Cities, New York Times
Some commuters rethink where they call home, USA Today
Suburbs a Mile Too Far for Some, Wall Street Journal
Area faces bleak real estate forecast, Seattle Post-Intelligencer
Oregon's "New West" tumbles, another sign of hard times
Seattle Times – Apr 12, 2009
Joseph Cortright, an economist with Impresa in Portland, said that Bend's fortunes have been tied to the collapse of the California housing market. …
Gresham hosts green economic summit
Portland Tribune – Mar 27, 2009
Joe Cortright of Impresa Consulting will kick off the summit with a presentation on the regional economy and Gresham's strengths. …
Minnesota Daily – Mar 9, 2009
Portland-based economist Joe Cortright of Impresa Inc. was a lead researcher for a 2004 study of the movements of 25- to 34-year-olds in major US metro …
Nature.com – Nature.com (subscription) – Feb 26, 2009
"Venture-capital firms measure cash flows in the billions of dollars," says Joe Cortright, a consultant based in Portland, Oregon. …
Federal aid won't come fast enough for Oregon
Oregonian – OregonLive.com – The Oregonian – OregonLive.com – Feb 14, 2009
Portland economist Joe Cortright warned against looking for quick results in Oregon. "What's happening in Oregon is really being driven by the national …
Nature.com – Nature.com (subscription) – Feb 13, 2009
And Joseph Cortright, an economist in Portland, Oregon, who specializes in the impact of biotechnology on regional development, calls the estimate of 500 …
Oregon City: Budget panel likely to look at cuts, increasing fees
Oregonian – OregonLive.com – The Oregonian – OregonLive.com – Feb 4, 2009
At the City Commission's recent retreat, members heard economist Joe Cortright predict that the decline in building permits — an important source of …
Thinking globally from the start, traders exported fur, logs, wheat…
Oregonian – OregonLive.com – The Oregonian – OregonLive.com – Feb 3, 2009
"The era of the Next Big Thing may be behind us," says Joe Cortright, a Portland economist and Impresa Consulting vice president. …
Unemployment Gets Ugly in Rural Regions
newwest.net – Feb 1, 2009
"Home construction has fallen off a cliff," Joe Cortright, a Portland economist, told The Oregonian newspaper. "When housing starts plummet, …
Illustration by Brett Superstar
Portland Mercury – The Portland Mercury – Jan 29, 2009
Last spring, CLF member and economist Joe Cortright came out swinging against the 12-lane option, releasing a report comparing the bridge's $4.2 billion …
Unemployment rate soars in rural Ore. counties
KCBY.com 11 – Jan 27, 2009
"Home construction has fallen off a cliff," Joe Cortright, a Portland economist, told The Oregonian newspaper. "When housing starts plummet, …
Oregon City: Officials hash out path to future at retreat
Oregonian – OregonLive.com – The Oregonian – OregonLive.com – Jan 21, 2009
Economist Joe Cortright told the group the city needs to finds its niche in the regional economy. Metro Chief Operating Officer Michael Jordan, …
Fans Push Council for Major League Soccer Support
Portland Mercury – The Portland Mercury – Jan 15, 2009
Last spring, CLF member and economist Joe Cortright came out swinging against the 12-lane option, releasing a report comparing the bridge's $4.2 billion …
|Oregon leaders look for hope amid economic gloomStatesman Journal – Dec 12, 2008
Beyond that, he and economist Joe Cortright of Impresa, a consulting firm, said it is too soon to say when the state might recover. …
Oregon's rural-urban divide has give and take Economies, politics…
$2.95 – Capital Press – NewsBank – Nov 20, 2008
$2.75 – PLANNING TO WAIT, BUY AT BOTTOM? LOTSA… – PressDisplay.com – Nov 16, 2008
Area faces bleak real estate forecast
Seattle Post Intelligencer – Nov 7, 2008
As 3 buildings open on research campus, PepsiCo announces lab plans
News & Observer – Oct 21, 2008
$2.95 – Charlotte Observer – NewsBank – Oct 19, 2008
CEOs for Cities President and CEO Carol Coletta to Discuss Elements…
earthtimes.org – Oct 2, 2008
Portlanders live in a like-minded bubble, making it easier to get…
Oregonian – OregonLive.com – The Oregonian – OregonLive.com – Sep 22, 2008
Westward halt! Gas prices slow expansion
Pay-Per-View – Chicago Tribune – ProQuest Archiver – Sep 21, 2008
Las Vegas Review-Journal – Las Vegas Review – Journal – Aug 10, 2008
'Next Washington' conference set for September in Lynnwood
Mid Columbia Tri City Herald – Aug 8, 2008
Bizjournals.com – Aug 1, 2008
Article Details – Daily Journal of Commerce.
Daily Journal of Commerce – Jul 22, 2008
Suburban flight: Commuting to work less attractive as gas prices soar
Wisconsin State Journal – Wisconsin State Journal – Jul 16, 2008
Wharton Unveils Initiative For Sustainable County
Memphis Daily News – Jul 11, 2008
ADAMCZYK: Greetings from the first ring
Tonawanda News – Jul 10, 2008
Will gas prices drive homebuyers away from suburbs?
Seattle Times – Jul 7, 2008
'The Big Sort': Red and Blue Divide Neighbors, Too
NPR – Jul 7, 2008
Suburban flight starts to hit home
pittsburghlive.com – Jul 3, 2008
Outlying suburbs are at a disadvantage
$2.95 – Record-Journal – NewsBank – Jun 30, 2008
Urban centers on the rise again
Pay-Per-View – Chicago Tribune – ProQuest Archiver – Jun 29, 2008
Interstate 205 bridge over the Columbia River may get tolls
Oregonian – OregonLive.com – The Oregonian – OregonLive.com – Jun 28, 2008
Portland Mercury | Blogtown, PDX | Rumble! It's the City Club Forum…
Portland Mercury – The Portland Mercury – Jun 27, 2008
Rethinking the Country Life as Energy Costs Rise
$2.95 – Ocala Star-Banner – NewsBank – Jun 25, 2008
Fuel Prices Shift Math for Life in Far Suburbs
New York Times – Jun 25, 2008
City Club of Portland's Friday Forum focuses on Columbia River…
$2.95 – Daily Journal of Commerce – NewsBank – Jun 24, 2008
The beginning of the end of sprawl?
Providence Journal – Jun 22, 2008
Suburbs a Mile Too Far for Some
Wall Street Journal – Jun 17, 2008
The Biz: Gas prices affect far-away homes, study says
Tampabay.com – Jun 15, 2008
Study: Suburban Pittsburgh home values declining as gas prices rise
Bizjournals.com – Jun 13, 2008
Preço da gasolina afeta todos os setores da economia americana
gazetamercantil.com.br – Jun 10, 2008
$4 per Gallon Gas Prices Affecting Entire Nation
U.S. News Rankings & Reviews – Jun 9, 2008
How the top biotech areas stack up
$2.95 – Miami Herald – NewsBank – Jun 9, 2008
Wealth Evaporates as Gas Prices Clobber McMansions
Bloomberg – Jun 9, 2008
COVER STORY: UM's bets on biotech future
$2.95 – Miami Herald – NewsBank – Jun 9, 2008
Gas prices may fuel growth in cities
Pittsburgh Post-Gazette – Pittsburgh Post Gazette – Jun 5, 2008
Questions abound for I-5 bridge project
Gresham Outlook – May 29, 2008
Portland forum planned for projections on population, jobs
$2.95 – Daily Journal of Commerce – NewsBank – May 29, 2008
Christian Science Monitor – May 21, 2008
When a city loses a corporate address
Seattle Times – May 18, 2008
Remodeled houses on tour – Single-family homes in five suburbs open…
$2.95 – Chicago Sun-Times – NewsBank – May 16, 2008
Peak-oil spike reshapes the suburbs
Georgia Straight – May 15, 2008
Pay-Per-View – Palm Beach Post – NewsBank – May 12, 2008
Commuting costs blamed as home prices fall
Palm Beach Post – May 11, 2008
Portland mass transit fills 'er up
Oregonian – OregonLive.com – The Oregonian – OregonLive.com – May 11, 2008
$2.95 – St. Louis Post-Dispatch – NewsBank – May 11, 2008
Some commuters rethink where they call home
USA Today – May 9, 2008
Brands have to elbow their way into consumers' consciousness and…
Oregonian – OregonLive.com – The Oregonian – OregonLive.com – Apr 24, 2008
Coffee Break: Coletta to run CEO for Cities
Memphis Commercial Appeal – Apr 8, 2008
BioCrossroads: it can happen here: report sees biotech jackpot, but…
Free with registration – Indianapolis Business Journal – AccessMyLibrary.com – Feb 4, 2008
Sustainable industries in Oregon claim success, despite lack of data.
Free with registration – Daily Journal of Commerce, Portland – AccessMyLibrary.com – Feb 4, 2008
Major projects will boost region's economy
Mail Tribune – Feb 1, 2008
Q&A with Portland economist Joe Cortright.
Free with registration – Daily Journal of Commerce, Portland – AccessMyLibrary.com – Jan 25, 2008
Oregonian – OregonLive.com – The Oregonian – OregonLive.com – Jan 25, 2008
"There's a 50-50 chance of recession, and we may yet avoid it," said Portland economist Joe Cortright, vice president of Impresa Inc. consulting. …
New chance for an old mill town CharlotteObserver.com – Charlotte,NC,USA People also want to know that if their company fails, they can walk down the street and get another job, said Joseph Cortright, an Oregon economist and …
Locals call for federal money for roads to boost economy
The Oregonian – OregonLive.com, OR – Nov 6, 2008
Small-scale maintenance projects would provide the best stimulus, Cortright said, because they would employ workers from the housing industry and could be …
OOPS! Portland's good intentions often have unexpected results
Portland Tribune – October 30, 2008
"The argument is made now that we build freeways to reduce congestion," Cortright says. "But it has the effect of stimulating additional travel.
Reasons for concern, not despair
The Oregonian – Oct 16, 2008
"Clearly, we're heading into a recession," said Portland economist Joe Cortright. "The next year or two are going to be a rough period for everyone. …
Portlanders live in a like-minded bubble, making it easier to get … The Oregonian – OregonLive.com – Portland,OR,USA We all know about young creatives college educated 25 to 34-year-olds such as Lieb whom Portland economist Joe Cortright says are flocking to cities such as …
|Fast Cities 2007 – Kevin Stolarick – CEOs for Cities – Institute for…Fast Company – Dec 19, 2007
We relied on CEOs for Cities' CityVitals survey, authored by Joseph Cortright of Portland, Oregon–based ImpresaInc.; sustainability data from SustainLane; …
Lightrail in Portland Is Successful, Despite CATO Criticism & FTA…
nationalledger.com – Oct 16, 2007
Economist in Tampa: Efficient 'green' transportation creates major…
Bizjournals.com – Oct 9, 2007
Steven Burrill, Scripps Florida, Red Hat, Roche Carolina Inc.,…
genomeweb.com – Apr 30, 2007
Steering Mill Towns Closer to Tech-Boom Riches
Subscription – Wall Street Journal Online – Dow Jones & Company – Feb 26, 2007
What UCF didn't tell us about biotech Orlando Sentinel, FL – Mar 5, 2006 … "There are huge business advantages to being in an area where other people are doing the same thing," says Joseph Cortright, an economist who co-wrote the …
Leaders seek to boost biotech sector Boston Globe, United States – Mar 9, 2006 … "It's an interesting proposition," said Joseph Cortright, an Oregon economist who studies the biotechnology industry. "But it strikes me as a big challenge."….
Wanted: The Young And Restless Hartford Courant, United States – Feb 26, 2006 By Carol Coletta and Joseph Cortright. Recent headlines about the latest census data on US cities have had city leaders – most notably …
Cities must retain the young, restless Albany Times Union, NY – Feb 26, 2006 By CAROL COLETTA and JOSEPH Cortright. … Joseph Cortright is an economist with Impresa Inc. They wrote this article for The Washington Post.
Scripps: Are Gardens, Jupiter bottleneck bound? Palm Beach Post, FL – Feb 18, 2006 … At least one economic analyst, Joseph Cortright, has declared that, if Palm Beach County thinks it's going to be the next big biotech hub, it's kidding itself….
Seeking the young & the restless Pittsburgh Tribune-Review, PA – Feb 15, 2006 By Carol Coletta & Joseph Cortright. Headlines about the … strengthening America's cities. Joseph Cortright is an economist with Impresa Inc.
To climb, cities grab key adults Atlanta Journal Constitution (subscription), USA – Feb 15, 2006 By CAROL COLETTA and JOSEPH Cortright. Recent headlines about the latest census data on US cities have had city leaders — most…
Wanted: The Young and Restless Washington Post, United States – Feb 12, 2006 … itself well in the race for talent. Joseph Cortright is an economist with Impresa Inc. Carol Coletta is president and chief executive …
Experts forecast city's future Arizona Republic, AZ – Feb 9, 2006 … When the out-of-towners took a tour of Chandler earlier in the day, Joe Cortright, an economic consultant from Portland, Ore.,….
Young at Heart: Finding The Key Demographic Needed To Revitalize America's Inner Cities Planetizen – January 10, 2005 Economist Joe Cortright and Carol Coletta, host of Smart City Radio and CEO of CEOs for Cities, outline the findings of their recent report, "The Young and the Restless in a Knowledge Economy".
More of the young and hip fight urban urge USA Today – Dec 28, 2005 … "They're very economically important to cities," says Joe Cortright, a Portland, Ore., economist who did the research for the CEO group. …
Employers, cities entice the young and the restless San Diego Union Tribune, United States – Dec 18, 2005 … to-date job skills – are more likely to be entrepreneurs and are more mobile than others in the work force, according to a study by economist Joseph Cortright …
Which Joel Kotkin to believe: the scoffer or the booster? Portland Oregonian, OR – Dec 11, 2005 … Maybe he's just confused. Joseph Cortright is an economist with the Portland consulting firm Impresa. He is co-author with Carol …
Cities' success tied to attracting young educated Chicago Sun-Times, United States – Dec 8, 2005 … economic future unless it succeeds in understanding and attracting the young, college-educated workers who propel today's knowledge-based economy," Cortright …
THE CORPORATE KICKER Portland Oregonian – Dec 8, 2005 … this wacky corporate lottery. Joe Cortright, of Northeast Portland, is an economist with Impresa Inc., a Portland consulting firm.
Young professionals critical to growing economies, report says Portland Business Journal, OR – Dec 6, 2005 Mirroring a local study he released in 2004, Portland economist Joe Cortright has released a national report emphasizing how important young, college-educated …
Barriers to biotech Charlotte Observer, NC – Oct 16, 2005 … Joseph Cortright, an Oregon economist who co-authored a biotech report for the Brookings Institution think tank, scoffed at the notion that biotech can change … Portland's New New Economy Willamette Week, OR – Oct 5, 2005 … "They're like the spotted owl," says local economist Joe Cortright, whose study of these phenomena is gospel among Portland boosters. …
San Antonio leaders defend city's bioscience push San Antonio Business Journal, TX – Oct 2, 2005 … Naysayers include Joe Cortright, co-author of a 2002 study on the US biotech industry sponsored by the Brookings Institution. Cortright …
Biotech payoff 'more prestige than payroll'
States spend millions in feverish pursuit of biotech Washington Business Journal – Oct 3, 2005 Four years ago, just 14 states had targeted biotech as a way to grow their economies. Today, 41 states are chasing the business. "That says a lot more about the herd instinct of people who do economic development in this country than the economics of biotechnology," says Joseph Cortright, a Portland, Ore.-based economist who co-authored a 2002 Brookings Institute study on biotech.
THE ECONOMIST: High-flying house prices fueled by fervor can't last
The Oregonian, July 17, 2005
Joe Cortright (Special to The Oregonian) "Hard as it is to imagine, those high-flying prices may be coming to an abrupt — and for some, painful — end. The sad truth is we're likely in the midst of a classic housing bubble."
Chasing biotech dollars in Phila. Philadelphia Inquirer, PA – Jun 19, 2005 … Joseph Cortright, a Portland, Ore.-based economist, said the biotechnology industry is prone to coagulate in areas where it already exists, rather than …
The bioinformatics dream gets a wake-up call Buffalo News, NY – Jun 19, 2005 … the author of a widely watched Brookings Institution study in 2002. Looking at research funding, patents and other factors, he found that biotech centers such …
City leaders discuss need for going global Rocky Mountain News, CO – Jun 16, 2005 … economies. "Figure out where you are the first, best or only," said Joe Cortright, an economist with Impresa Consulting in Portland, Ore. …
Betting on biotech San Diego Union Tribune, CA – Jun 1, 2005 … "It's essentially like a casino," said Joseph Cortright, a Portland, Ore., economist. "There are lots of bets you can lay down and …
Biotech's hype, hope yield losses Globe and Mail, Toronto, Canada – Jun 1, 2005 Cortright, who co-wrote a report critical of biotechnology's ability to drive a region's economic growth, says local government officials who promise companies also sorts of incentives to relocate are ignoring the industry's financials. "The mistake that people make is confusing science that is really cool with something that is going to have a significant economic impact," he said.
San Francisco: Stem cell's Silicon Valley? USA Today – May 2, 2005 . .. Joe Cortright, a Portland, Ore., economist who tracks biotech, says the city landing the institute will be better positioned to gain supremacy in the biotech …
Valley has 'grown up' after 18 years but still has far to go Arizona Republic, AZ – May 1, 2005 … at ASU is part of that combination of Knowledge Economy/biotech, bioscience capacities in a … But a recent study by the Brookings Institution suggests you're not …
15 reasons San Francisco is the right city for the stem cell … San Francisco Examiner, CA – Apr 28, 2005 … According to a 2002 study by Cortright and. Mayer, the Bay Area ranked first in venture capital investment in biotech from 1995-2001. …
Malaysia's biotech folly Asia Times Online, Hong Kong – Apr 27, 2005 … A study of 51 biotech centers in the US by the Brookings Institution revealed that it often takes a decade or more to develop biotechnology-based products, and …
In Portland, living the green American dream Christian Science Monitor – April 26, 2005 More young urban professionals are forgoing square footage for eco-friendly homes….Well-educated young people are disproportionately drawn to Portland, according to Joe Cortright, economist and coauthor of "Young and Restless: How Portland Competes for Talent," a study of the migration of 25- to 34-year-olds across the US. "In focus groups people said Portland is a place where you can live your values, and environmentalism is clearly one of them."
Merix dips its toe into Asia acquisitions game Portland Tribune, OR – Apr 19, 2005 … "Anybody who's in that industry and in a lot of other manufacturing industries really has to have a global strategy," said Joseph Cortright, an economist …
The half-full case for ScrippsPalm Beach Post, FL – Mar 21, 2005 … I wrote about economist Joe Cortright, who testified on behalf of environmentalists about the difficulty of turning Palm Beach County into a biotech hub simply ..
Bioengineered Pork Seattle Weekly, WA – Mar 22, 2005 … area alone, according to Joseph Cortright, an independent Oregon economist and co-author of an influential study on how cities and states are pursuing biotech. …
US Science Policy: Upstart States Nature – March 2, 2005 Cortright isn't convinced by the ambitious Scripps Florida project. "I am extremely sceptical that it will produce any kind of biotech industry there.
Stem cells' promise pits jobs vs. values: States want biotech business USA Today – Feb 16, 2005 … in 2003 to spend $310 million for a Scripps Research Institute near Palm Beach. … biotech economic development at consultant Impresa in Portland, Ore. …
Portland's New Pioneers, by Joe Cortright Portland Oregonian, Sunday, Dec. 12, 2004 They're young, creative and seek and quality of life not found elsewhere –and the region's economic rebound rests on their tech-savvy shoulders as Joe Cortright explains in this feature in the Commentary section of the Oregonian.
Portland Mayor Vera Katz highlights young and restless in her farewell "State of the City" address, December 10, 2004 ". . . our economy is very different from the economy that existed just two decades ago. The industries rooted in our pioneer heritage are being supplanted by new types of pioneers. Many of these pioneers are those educated young adults that some call "the creative class," but who I refer to as "the young and the restless." They're drawn here in great numbers by our city's beauty, by our culture, by our affordability and by our reputation for innovation. Being young, they know the greatest constant in the world today is change. They are comfortable with it. They find opportunity in change. So should we."
Biotech's future far from a sure thing East Valley Tribune, AZ – Dec 19, 2004 … In fact, many of the breakthroughs in biotech are more expensive than the earlier treatments, said Portland, Ore.-based economist Joseph Cortright. …
Group For Young Professionals Emerges As Instant Success Tampa Tribune, FL – Dec. 16, 2004 … The study was conducted by Coletta and economist Joe Cortright, vice president of Impresa Inc., a Portland-based consulting firm that specializes in economic ..
Lottery's slot option freshens rate debate Portland Oregonian, Dec. 8, 2004 Joe Cortright, a Portland economist who regularly contracts with government and business groups, estimated that an average rate of 17.8 percent would give …
Governor, senators call for better schools, technology Corvallis Gazette Times, OR – Dec 7, 2004 … costs. He also wants a rainy day fund to protect the state from economic downturns. Joe Cortright, an economist with Impresa Inc. who …
Study: Phila. must do more to retain young adults The Daily Pennsylvanian, December 8, 2004
Attracting young workers is key in 'creative economy,' study says
A bid to lure & retain 'Young & Restless' Philadelphia Daily News, Dec. 8, 2004 They are called the young and the restless – college-educated 25- to 34-year-olds – and experts say keeping them employed and living in your city is the key to future economic prosperity. They have the most current education, work the longest hours to build careers and are inexpensive workers. But they are mobile, ready to split the city any time. And during the 1990s, the Philadelphia region lost 195,000 of these young workers, according to a new study co-authored by Carol Coletta, the . . .
Editorial | Start spreading the news: Innovation Philadelphia Philadelphia Inquirer, Dec. 6, 2004 Economist Joseph Cortright of Impresa Inc., who collaborated on the Young and the Restless study, said that keeping even a few more of those students – keeping them from heading out to New York, Washington, Boston, Austin or the West Coast – could make a huge difference.
Economist: Need to Invent Next Oregon Economy Oregon Public Broadcasting, Dec. 7, 2004 Economist Joe Cortright told the group that state's recession has accelerated changes in Oregon's economy. "I think what we realize that we won't recover the same jobs that we lost. We don't have the option of going backwards. We only have the option of going forwards. And the challenge then is to invent the next Oregon economy."
Wireless advantages explained Commercial Appeal (Memphis), TN – Nov 9, 2004 … Newcomers will relate first impressions and Portland, Ore.-based economist Joe Cortright will talk about cultivating difference and attracting talent via …
National rankings show fair progress Bangor Daily News, ME – Nov 7, 2004 … moved to increase its investment in the whole area of biotechnology in the … But a Brookings Institution study concluded earlier this year that while the area …
Armageddon for the GOP Seattle Weekly, WA – Oct 26, 2004 … Economist Joe Cortright, author of a study of biotech for the Brookings Institution, says, "Biotechnology is not a transformative force in the economy …
State biotech sector no miracle drug for creation of jobs Seattle Times, WA – Oct 15, 2004 … Biotechnology can create exceptional medicines and stockholder wealth. … Seattle, San Francisco and Boston, a 2002 report by the Brookings Institution found 3.5 …
San Jose Mercury News, October 12, 2004 But some economists warn that drug manufacturing is still a tiny industry dominated by a few big companies and highly concentrated in a few regions of the country. Drug companies like to "cluster" around universities and each other so they can easily swap — and steal — technology and scientists, making it difficult for regions to launch a biotechnology industry from scratch, said Joseph Cortright, a Portland, Ore., economist who co-wrote a report on the subject.
Biotech Biorhythms Tech Central Station – Jul 7, 2004 … to ever experience the joy of growing biotech clusters? Not necessarily, but politicians should be realistic in their planning. The Brookings Institution said …
OHSU sees drop in award rankings Oregonian, OR – Jul 4, 2004 … ranking? Not likely, said Portland economist Joe Cortright. "There's an enormous amount of stability in the rankings," Cortright said. …
Cities extend invitation to younger folks Seattle Times, WA – June 29, 2004
COVER STORY: Bio-piracy and law of jungle New Straits Times, Malaysia – Jun 26, 2004 … On making money out of biotech, an Associated Press report on Bio 2004 quoted economist Joseph Cortright as saying that luring biotech in the hope of saving a …
Midsize cities working to hook young professionals Houston Chronicle, TX – Jun 26, 2004 … areas in the United States had more 25-to-34 year olds in 2000 than they did in 1990, according to an analysis by economist Joseph Cortright, who studies …
Attracting the 'young and restless' Hillsboro Argus, OR – Jun 24, 2004 … Joe Cortright of Impresa Consulting and Carol Coletta of Coletta & Co. … Cortright and Coletta compared the Portland region with five other metro areas. …
Portland's wealth can be measured in youth movement Oregonian, OR – Jun 23, 2004 A new study by Portland economist Joe Cortright and Memphis , Tenn. , urban consultant Carol Coletta documents and examines the continuing migration of young …
What future Houston could be like in 2025 Houston Chronicle, TX – Jun 19, 2004 … The Brookings Institution had already confirmed Houston as one of most upwardly mobile urban … it to continue to grow into one of the great biotech centers of …
Mike Ivey: Competition strong for building biotech The Capital Times, Madison, WI – Jun 15, 2004 … This notion that you lure biotech to your community to save its economy is laughable," said Joseph Cortright, a Portland, Ore., economist who co-wrote a …
Not all that's outsourced gone abroad Oregonian, OR – Jun 15, 2004 … contract out the rest. "It's a structural change in the economy," said Joe Cortright, a Portland economist. "It's this ongoing process …
Biotech's future in Florida no sure thing Fort Lauderdale Sun Sentinel, FL – Jun 13, 2004 … is laughable," said Joseph Cortright, an economist from Portland , Ore. , who co-wrote a 2002 Brookings Institution report on the state of the biotech industry. …
EDITORIAL: Unlocking biotech potential New Straits Times, Malaysia – Jun 12, 2004 … We should also draw from the lessons of the 2002 Brookings Institution study which indicated that the two key elements for biotech growth are strong research …
Study explores 'young, restless' Sarasota Herald-Tribune, FL – May 21, 2004
Can deal put city in biotech major leagues? Houston Chronicle, TX – May 11, 2004 … The odds are stacked against Houston and most other cities trying to develop major biotech centers, said Joseph Cortright, a Portland, Ore., economist who co …
BIOTECH MECCA South Florida Sun-Sentinel, FL – May 11, 2004 … The chances of creating more centers are slim, said Joseph Cortright, an economist in Portland, Ore., who co-wrote a 2002 Brookings Institution report on the …
San Francisco Federal Reserve Bank, Economic Review, "Performance of Urban Information Technology Centers:The Boom, the Bust, and the Future" by Mary Daly and Robert G. Valetta, (Spring 2004)
Biotech Magnet: Loudoun County Hopes Medical Research Campus Will Trigger a Boom Washington Post, March 7, 2004
Steve Novick: Evidence overwhelming on lottery commissions Oregonian, OR – Feb 15, 2004 … In 1994, economist Joe Cortright studied this issue for the Legislature. Based on careful, on-site analysis of the retailers' finances …
Biotech business has potential in rural Minnesota USA Today – Feb 15, 2004 … Experts say attracting biotech businesses isn't easy. A Brookings Institute study last year concluded most efforts will fail, even in large cities. …
Is biotech getting spread too thin? Palm Beach Post, FL – Feb 14, 2004 … a community to have," says Joseph Cortright, an economist in Portland, Ore., and co-author of a 2002 Brookings Institution report on the state of the biotech …
Chase for biotech billions pits city against many rivals Portland Tribune, OR – Feb 10, 2004 … Nearly every metro area has similar hopes and dreams," said Portland economist Joe Cortright, the co-author of a 2002 study of the US biotech industry. …
Diverse groups seek common ground on growth Oregonian, OR – Feb 1, 2004 … Unlike general industries such as restaurants and retail shops, high-tech businesses tend to congregate, economist Joe Cortright told the group. …
Study finds life science specialties Indianapolis Star, IN – Jan 28, 2004 … Joe Cortright, an economist at Portland, Ore.-based Impresa Consulting, said few of the life science initiatives budding across the country will prosper. …
Biotech panel considers recruiting aid Minneapolis Star Tribune, MN – Jan 25, 2004 … an economist with Impresa Inc., of Portland, Ore., and the author of the much-quoted 2002 Brookings Institution study on economic development and biotech. …
Opinions vary on 316's future Atlanta Journal Constitution, GA – Jan 25, 2004 … Joe Cortright, an economist with Impresa Consulting in Portland, Ore., said high tech employment nationwide has dropped up to 20 percent over the past two years …
Selling of biotech initiative to have new focus Miami Herald, FL – Jan 25, 2004 … Focus is the key to a successful plan, says Joe Cortright, a consultant based in Portland, Ore., who did a study of the biotech industry for the Brookings …
Eastbank freeway: Same old fights Oregonian, OR – Jan 24, 2004 … the district might just be sprouting the kind of "creative economy" of youthful, educated entrepreneurs that economists like Richard Florida and Joe Cortright …
PDC chief takes the offense Portland Tribune, OR – Jan 23, 2004 … out-of-state companies has ground to a halt, largely because of the sour state of the economy, not "our (lack of) prowess as recruiters," said Joe Cortright, …
Highly Concentrated Growth Los Angeles Times, CA – Jan 23, 2004 … young scientist in San Diego or Boston, why would you want to leave?" said Cortright, who wrote a 2002 study on the nation's biotech industry for the Brookings …… Biotech isn't like Krispy Kreme," whose growth depends on expansion into new territories here consumers hunger for doughnuts, said economist Joseph Cortright. …
Biotechnology: Rolling the Dice Florida Trend, FL – Dec 31, 2003 … All of California has fewer than 450 biotech firms. Several sources, including Ernst & Young, the Institute for Biotechnology Information and the Brookings …
Economic recovery expected to take hold Oregonian, OR – Dec 31, 2003 … All in all, said Joe Cortright, an economist with Impresa, a Portland consulting firm, 2004 holds at least as much, if not more, promise for the area than 2003 …
Why Boston covets its role as biotech hub Christian Science Monitor – Dec 24, 2003 … Plus, biotech factories pollute less and require less energy than other industries. … as one of their top two targets for industrial development, a Brookings …
Baltimore Makes a Bold Bid To Transform Neighborhood Washington Post, December 1, 2003; Page A1, By Michael Barbaro "This is a mania," said Joseph Cortright, an economist who has written extensively on the development of biotech centers. "Ten years ago, everyone wanted to be the next Silicon Valley. Three years ago, they wanted to be the center of e-commerce. Now that both of those have fizzled, everyone in the economic development fraternity thinks they need to be in biotechnology."
Scripps will bring many so-so salaries Orlando Sentinel, FL – Nov 26, 2003 … the La Jolla research institute, but the biotech cluster that sprung up around it in California is far more difficult to replicate here, said Joseph Cortright …
Business Facilities (magazine), "US Biotech's Top 40," (November)
Biotech Land Rush, by George Howland Jr. Seattle Weekly, WA – Nov 20, 2003 The region's leaders have caught biotech fever, and economist Joseph Cortright says that can be an unhealthy obsession. "Biotech …
Life in US Biotech? The Scientist, – Nov 20, 2003 Still, the industry employs relatively few technical workers overall. The Commerce Department estimates that a total of 34,000 scientists work for biotech companies, and the vast majority of these jobs are located in just six states. Even for cities with a high concentration of biotech, such as Boston and San Francisco, the largest companies still rank as only minor employers in the region, a Brookings Institution report found last year.
Selling points Oregonian, OR – Nov 9, 2003 Joe Cortright's commentary on why "Things Look Different Here" isn't such a bad slogan for Oregon.
Westside forum on the economy gives equal time to quality of life Oregonian, OR – Nov 8, 2003 … Her comments dovetailed with economist Joseph Cortright's presentation of the final phase of his westside economic study. "A critical …
Economists eye long-term growth for Washington Co. Katu.com, OR – Nov 7, 2003 … If we stand still, if we don't innovate, if we don't create new companies, then clearly we could be too dependent," said economist Joe Cortright. …
The Man Who Would Be Kings Village Voice, NY – Nov 4, 2003 … It may be a zero-sum game, where money spent at the ballpark is not spent somewhere else," says Joe Cortright, a former economist for the Oregon state …
States flock to biotech like gamblers to lottery tickets USA Today – Nov 3, 2003 … relocate. Going after biotech jobs is akin to "spending your life's savings on lottery tickets," says economist Joe Cortright. He …
The Nine States of Oregon Oregonian, OR – Nov 1, 2003 … In the new economy, said Portland economist Joe Cortright, the urban area is an important gateway for the rest of the state — what he only half-jokingly calls …
Leaning left, Portlandia looks to right itself Oregonian, OR – Nov 1, 2003 … Joe Cortright, a Portland economist working on a study of this age group, said the relative scarcity of people in this age range makes them a valuable commodity …
LSI's tax incentives in the spotlight Oregonian, OR – Oct 30, 2003 … It remains to be seen whether there's any bounce at the bottom of this down cycle," said Joe Cortright, a Portland-area economist with Impresa Consulting. …
To avoid 'brain drain,' can bay area learn to be hip? St. Petersburg Times, FL – October 27, 2003 … Regional economist Joe Cortright of the Impresa consulting company in Portland, Ore., will steer the study. "Historically, this …
Can Florida become a high-tech state? Sarasota Herald-Tribune, FL – Oct 26, 2003 … I am skeptical," said Joe Cortright, a Portland, Ore.-based consultant who did a study of American "biotechnology centers" last year for the Brookings …
Scripps envisions its dream home South Florida Sun-Sentinel, FL – Oct 26, 2003 … Joseph Cortright, author of a 2002 study for the Brookings Institution on biotech clusters, said Scripps' prowess as an economic magnet is overrated. … Marketplace Morning Report, October 22, 2003 (RealAudio Feed) From San Diego: Eric Niiler explains why Florida is trying to lure Scripps' biotech research work out of San Diego. (Public Radio)
Hardwoods law at core of debate Coos Bay World, OR – Oct 22, 2003 … But Joe Cortright, an economist and consultant representing the petitioners, disputed Taylor's view and said the new entrants into the alder business were …
Retailers set sail for southwest suburbs Oregonian, OR – Oct 22, 2003 … Companies such as West Marine — specialized concerns with regional drawing power — face equally specialized decisions in whether to expand, said Joe Cortright …
State Hopes To Cash In On Biotech The Ledger, Florida – Oct 20, 2003 … Joseph Cortright, author of a 2002 Brookings Institution study on the nation's biotech clusters, said the industry is concentrated in nine metropolitan areas …
$510-million catalyst St. Petersburg Times, FL – Oct 19, 2003 … Joseph Cortright, author of a 2002 Brookings Institution study on the nation's biotech clusters, said the industry is concentrated in nine metropolitan areas …
Biotech plans: Boon or fantasy? … shot at best," said Joseph Cortright, an economist … biotechnology industry study for the Brookings Institution … for the most part, these [biotech] companies are …
ST. PAUL: City takes next steps on biotech St. Paul Pioneer Press, MN – Oct 16, 2003 … A Brookings Institution study last year also listed Minnesota as an also-ran in what is likely to be a highly competitive industry …
Mid-sized cities get hip to attract young professionals USA Today – Oct 10, 2003 … elsewhere. "Bill Gates is pushing 50," says Joe Cortright, head of Impresa Inc., an economic consulting firm in Portland, Ore. "The …
Oregon firms smorgasbord loses entree Oregonian, OR – Oct 10, 2003 … Joe Cortright, an economist with Portland-based Impresa, attributed some of the industry strength to Oregonians' willingness to try new foods. …
High-tech plan pays off for Tualatin Oregonian, OR – Oct 1, 2003 … Novellus is certainly a nice tenant to have here," said Joe Cortright, an economist and vice president for Impresa, a Portland-based consulting firm. … Oregon Business, "Footwear and Apparel: A Cluster of Giants" (October)
Economic vital signs show hints of new life Oregonian, OR – Sep 13, 2003 … One reason, Portland economist Joe Cortright said, is that businesses are still reaping the benefits of an earlier spree of investment in information …
Sawmills battle Weyerhaeuser Oregonian, OR – Sep 10, 2003 … Economist Joe Cortright, who was hired by the small mill owners, said banning Weyerhaeuser from buying state-forest logs would help open the industry …
No urban/suburban divide Oregonian, OR – Sep 9, 2003 Economist Joe Cortright's recent "Westside Economic Study" provides overwhelming evidence that livability is and will be a key economic asset. …
Housing market still booming Oregonian, OR – Sep 3, 2003 … Diversified economy helps One reason for that is the region's more diversified economy, said Joe Cortright, an economist with Impresa Consulting. …
Portland Oregonian, "Sports Apparel Seeks Respect at the Top" , (August 2)
Portland Oregonian, "Cutting a new direction" (OHSU Plans for biotechnology), (August 2)
Sacramento Bee, "Area push to boost biotech industry" (August 1)
Richmond Federal Reserve Bank , Regional Focus, "Seeing the Light," by Charles Gerena, (Summer 2003)
Hillsboro Argus, "Building a biotech industry in Oregon may take decades" (July 24)
Portland Oregonian, "In a state of unemployment," (July 19)
Portland Tribune, "NAFTA takes a blue-collar bite," (July 18)
Portland Tribune, "Jobless rate- not as scary as it looks" (July 15)
Columbia (SC) State: "How SC's $12 million bet on biotech soured," (July 13)
St. Paul Pioneer Press, "U. Buys into Biotech," (July 7)
Seattle Times, "A Hub of Tax Breaks for South Lake Union Biotechs," (June 16)
Portland Business Journal, Economist argues for the long view in building tech (May 15)
Minneapolis Star Tribune, "State has long way to go to become biotech center, (May 10) Hillsboro Argus, "Local officials share their concerns about county's future," (May 6)
The Scientist, "Indiana Wants You" (Volume 17, Issue 5) (May 5) Salem Statesman Journal "House to visit stadium funding" (May 5)
Dallas Federal Reserve Bank (San Antonio Branch), Vista, "Biotech and the San Antonio Economy," by Keith Phillips and Maria Ritka Dzula , (Spring 2003)
Portland Tribune, "Big hopes, bad times" (Apr 22) Seattle Times, "Cities hang their hopes on building up biotech" (April 21)
Portland Oregonian, "Hillsboro cuts in school days trigger alarm (April 17)
San Diego North County Times, "San Diego's bursting bio-diversity" (April 13) Toronto Globe and Mail, "US cities compete for biotech dollars" (April 8)
Phoenix Arizona Republic, "State mapping biotech's future" (March 29)
London, The Economist, "Cluster analysis: Like birds of a feather, biotech firms flock together (March 27)
Joe Cortright's Op-Ed: "Rural Revival," Portland Oregonian, (March 9)
Sacramento Bee, "Will capital area be biotech mecca?," (March 4)
Indianapolis Business Journal, "Life Science Initiative Selects Targets" (March 3)
Plant Sites & Parks, "Biotechnology: Industry of the Future" (March)
Portland Oregonian, "County's economy hinges on rebound in chip-making, (February 26)
Denver Rocky Mountain News, "Reuteman: Colorado in position to gain after dust settles" (February 15)
Portland Oregonian, "State must risk to keep tech edge" (February 4)
Portland Brainstorm Magazine, "Banking on Biotech" (February)
Portland Oregonian, "Portland, Multnomah County don't have aid for schools in plans" (January 30)
Portland Oregonian, "State's biotech firms trail others in growth, study says" (December)
Hillsboro Argus "Economist expects turnaround in local economy by late 2003" (December 12)
Willamette Week, "Anywhere, USA" (December 11)
Philadelphia Federal Reserve Bank , Business Review, "From Laboratory to Market: The Biotechnology Industry in the Third District," by Timothy Schiller, (Fourth Quarter 2002)
Portland Oregonian, "Business leaders call for sales tax" (December 10)
Denver Business Journal, "Institute will produce 'plan' for Colorado's biotech industry" (December 6) Portland Oregonian, "Destination PDX: a youth culture convergence" (December 1)
Industry Week, "Questioning Biotech's Benefits" (November)
New York Federal Reserve Bank (Buffalo Branch), The Regional Economy, "Vitality in Upstate Medical Manufacturing" by Richard Deitz and Ramon Garcia, (Fall 2002)
Seattle Times, "Seattle and San Diego: Reflections on two cities" (September 15)
Kansas City Federal Reserve Bank, Economic Review, "How High Tech is the Tenth District," by Chad Wilkerson, (2nd Quarter, 2002)
Portland Tribune, "What's right with Portland: a lot" (August 30)
Portland Oregonian, "Area's Economic Future Lacks Battle Plan" (August 18)
Austin American-Statesman, "Austin boom in '90s part of creative shift in U.S.: Migration of talented, highly paid workers creating new landscape" (August 4)
London Financial Times, "A risky experiment in biotechnology" (June 26)
Seattle Times, "Economic Memo: Risk and biotech go together" (June 23)
Portland Tribune, "What's up?: As job growth increases a bit, forecasters pin an economic comeback on certain sectors" (June 14)
New York Times, "Cities and States Clamor to Be Bio Town, U.S.A." (June 11).
Wall Street Journal, Desperately Seeking To Lure Biotechnology Businesses, (June 11)
Business Week, "So you want to be a biotech hotbed?" (June 13)
Toronto Star, "Too many cities want to be biotech centres" (June 13)
Philadelphia Inquirer, "A new industry could provide new lifeblood" (June 12)
Raleigh News & Observer, "A growing industry and the Triangle is a Leader" (June 11)
Site Selection, "Biotech Not Everywhere Despite Claims to the Contrary" (June)
Public Radio International–Marketplace "Biotech Cities" (June 11)
San Francisco Chronicle, "Biotrends: Two major reports highlight the globalization of biotechnology and the battle within the U.S. for regional supremacy" (June 10)
Portland Business Journal, "Westside Economic Summit Seeks Economic Development Direction" (April 3)
Milwaukee Journal Sentinel, "Biotech research touted as prime market to tackle" (March 20)
Portland Tribune, "Urban growth boundary's bad rap may be bunk" (March 19)
Seattle Times, "Oregon's downturn: State battered by slump in manufacturing" (January 13)
Portland Tribune, "Tech still powers Oregon economy" (December 4)
Willamette Week, "Tales from the New Economy – Q&A: Joe Economist" (November 21)
Wall Street Journal, "Economic roil hits Northwest: Once booming area faces downturn after blows to multiple sectors" (October 17)
Minneapolis Star Tribune, "New study finds a stronger Minnesota high-tech sector (August 7, 2001)
Minnesota Public Radio, "Gay Index Measures High Tech Success" (June 5)
New York Federal Reserve Bank (Buffalo Branch), The Regional Economy, "The Information Technology Industry in New York State," by Richard Deitz and Ramon Garcia, (Spring 2001)
The Arizona Republic, "Venture capital chump change could raise big interest in Arizona" (January 29)
Washington Post, "Weathering the Tech Shakeout" (January 16)
Portland Oregonian, "Study illustrates nuances of high tech" (January 16)
Austin Statesman, "Technology and Tolerance: Austin Advantages" (June 25)
Portland Oregonian, "In Washington County, High Tech Digs In" (May 18)
Earlier News
Portland Oregonian, "EconData.Net gives easy access to local, regional economic data" (December 20)
Portland Oregonian, "A Growing Gap" (October 3) [Oregon's rural counties aren't keeping pace with the Portland area in terms of the number of jobs and wages]
Portland Oregonian, "Study Finds Fast Lane Businesses, aka Gazelles in Short Supply" (October 3)
Portland Oregonian, "Its One Oregon, Not Two", (January 31)
Willamette Week, "Who's Supporting Who?: Challenging a widely held misconception about state funding"(January 27)
Portland Oregonian, "Legislature Casts Aside Valuable State Resource" (August 8)
Portland Oregonian, "Cashing in on Video Poker" (February 17)


text:
Type: Part Time Download/print details
Download PDF application form Enquire
Course Details
The course will cover all aspects of studio pottery.
Basic techniques, coiling, slab building, throwing on the wheel, press moulding, glazing and decorating techniques.
Practical 'Hands on' approach. Demonstrations followed with technical support.
Information & Support
Suitable for all levels of ability.
What do I need to bring to the course?
Overall recommended.
Additional course costs.
Students are expected to purchase all completed work to cover the cost of glazing and materials. A contribution may be asked for uncompleted work. Basic tools are provided but students may wish to collect their own specialist tools.
Courses are run continually, and you will be able to join these to further develop your skills.

subset: commoncrawl


text:
Organize your life in style.
Gain cool factor this spring by becoming a master at making slushies! Blue ChillFactor Frozen Drink Maker features a round, flexible rubber exterior with raised and twisted lines for gripping, an insulated ice pack interior, and a plastic lid, washer, and funnel on top.
Use this handy cup with the included plastic straw and spoon attachment to enjoy refreshing frozen drinks in steps as easy as 1-2-3! Simply freeze the container, squeeze the bottle once the liquid is added through the funnel, and enjoy chilled drinks in less than a minute. Use this revolutionary Rapid Freeze Technology for a fun and flavorful season ahead!
Staw with Spoon
Note: Funnel, washer, and collar are top-rack dishwasher safe. Lid, cup, and cooling pack are hand washable only. Suitable for exposure to temperatures in the range of -25° to +60° C
Inspired?Share it:
I love it! Add to wish list


text:
Home | Contact Us | Link to Us
Products of this category
Rental Property Manager 3.0
Rental Property Manager is a one-stop database for managing your rental property information. Using RPM, you can save and manage data about your properties, tenants, and financial transactions.
Rental Property Manager is a one-stop database for managing your rental property information. Using RPM, you can save and manage data about your properties, tenants, and financial transactions.
Software License Tracker Pro 2.9
Software License Tracker Pro is a flexible software license management system for Windows users.
Software License Tracker Pro is a flexible software license management system for Windows users.
IMM Conversion 6.05
Now users can easily get IMM Conversion to PST, MBOX and EML with the help of IncrediMail IMM Converter Tool. The Software would assist users to Convert IMM Emails to PST, MBOX and EML with accurate manner.
Now users can easily get IMM Conversion to PST, MBOX and EML with the help of IncrediMail IMM Converter Tool. The Software would assist users to Convert IMM Emails to PST, MBOX and EML with accurate manner.
New softwareCheewoo VaryTable Speedy Claims CMS 1500 Doxillion Document and PDF Converter Free Mac AllMyNotes Organizer Portable NCheck Bio Attendance Trial for Windows PHP Auction Script Hotelare Bolt PDF Printer Free Rapid PDF Count Jihosoft iTunes Backup Unlocker Mac BuzzBundle Enterprise AMGtime Software Viral Master List Builder Product Locator Jihosoft iOS10 Backup Extractor TimeCard Plus TimeCard Standard VeryPDF PDF to Image Converter VeryPDF PDF to Text OCR Converter CMD VeryPDF PDF to ePub Converter CMD Paper Killer Doxillion Document Converter Free Mac BuzzBundle Enterprise Free iTunes Backup Extractor for Mac Free iTunes Backup Extractor
Bytescout BarCode Reader 188.8.131.521
License: Freeware
Size: 4.0 MB
Date added: 2016-11-21
Date updated: 2016-11-21
Downloads: 149
Downloads - Last week: 1
Bytescout BarCode Reader is able to read barcode from image (PNG, JPG, TIFF, GIF) , read barcode from PDF, you may copy a barcode value as text (you can select and copy extracted value). BarCode Reader can be used to read barcode from live Web camera (just put the object or paper to the camera and the utility will decode a barcode)
The freeware software is based on Bytescout BarCode Reader SDK for Windows desktop and web software developers
OS: Win7 x32,Win7 x64,Windows 8,Win2000,WinOther,WinVista,WinVista x64,WinServer,WinXP,Windows 10
System Requirements: Windows XP or higher
Keywords of Bytescout BarCode Reader
Downloads from ByteScout, Inc
Bytescout PDF To HTML SDK 188.8.131.5297 - PDF To HTML SDK allows developers to convert PDF to HTML preserving the layout without any additional software required. Extracts images and fonts from PDF. Provides .NET and ActiveX interface, 100% managed C# code. ... (21/1) download
Bytescout BarCode Generator SDK 220.127.116.111 - Generate barcodes from .NET with Bytescout BarCode Generator SDK which provides 4 types of controls to generate, display, save barcodes: Windows Forms, WebImage Control (ASP.NET), SSRS control, ActiveX. Supports almost all barcodes (1D and 2D types). ... (25/1) download
Bytescout BarCode Reader SDK 22.214.171.1241 - Can read barcode from image, read barcode from PDF, read barcode from TIF in your Windows desktop and web applications. Reads QR Code, Code 39, Code 128, EAN-13, UPCE, UPCA, Aztec, PDF 417, MICR and lot lot of others. Reads PDF and TIFF images. ... (0/0) download
Bytescout SWF To Video SDK 2.12.1012 - Flash to video converter SDK to convert SWF and FLV to AVI and WMV videos with ease. Includes .NET and ActiveX interfaces. Supports 2 modes: frame by frame and swf-with-live-data (to convert SWF with external FLV, images or XML). ... (0/0) download
Bytescout Screen Capturing SDK 2.51.976 - Screen Capturing SDK makes screen cast recording (WMV, AVI) as easy as 5 lines of code in your VB, C# or C++ application. Provides mouse cursor hot spot, audio recording, record from entire screen, selected window, region, region around the mouse. ... (1/0) download
Bytescout BarCode Generator 22.214.171.1245 - BarCode Generator is able to generate and export barcode to image (PNG, JPG, TIFF). Types: Codabar, Code 39, GS1, Code 93, Code 128, EAN-13, EAN-8, JAN-13, Bookland, UPC-A, UPC-E, Postnet, PDF417, Truncated PDF417, DataMatrix, QR Code ... (0/0) download
ByteScout PDF Multitool 220.127.116.1197 - PDF Multitool (FREEWARE) includes set of functions to extract data and text from PDF files: PDF To XML, PDF To CSV, PDF To Text, reading text from scanned PDF using OCR, search text with regular expression, extract original images and much much more ... (3/1) download
ByteScout PDF Extractor SDK 22.214.171.12497 - PDF Extractor SDK allows developers to convert PDF to text, PDF to XML, extract images from PDF, convert PDF tables into CSV for Excel, extract information about PDF file in .NET or ActiveX interfaces. Works without any additional software required. ... (0/0) download
ByteScout PDF Renderer SDK 126.96.36.19997 - PDF Renderer SDK for .NET, ASP.NET, ActiveX converts PDF to PNG, TIFF, BMP, PDF to EMF metafile. PDF Renderer SDK does not require any other software installed (no other PDF software is required) and works in .NET, ASP.NET, x64 Windows. ... (0/0) download
Bytescout Spreadsheet SDK 2.80.1582 - Read and write XLS, XLSX from ASP.NET, .NET, VB, C#, PHP and other programming languages without Excel installed! Supports formula calculations, text formatting, rows, columns, sheets management and much more! ... (0/0) download
Similar Searches by Users
Related Press, Software News


text:
Listen to all music and sounds of Futuredraht and follow this user by signing in for free.
You can listen to 29 tracks and mixes and follow this user as 33 did before.
This artist liked 11 tracks, followed 33 others and reshared 11 tracks and mixes. 4 other people are following this page too.


text: 3. As of noon trading, Health Care REIT ( HCN) is down $0.81 (-1.2%) to $67.48 on average volume Thus far, 858,375 shares of Health Care REIT exchanged hands as compared to its average daily volume of 2.2 million shares. The stock has ranged in price between $67.48-$68.44 after having opened the day at $68.28 as compared to the previous trading day's close of $68.29. Health Care REIT, Inc. is an independent equity real estate investment trust. The firm engages in acquiring, planning, developing, managing, repositioning and monetizing of real estate assets. It primarily invests in the real estate markets of the United States. Health Care REIT has a market cap of $19.3 billion and is part of the real estate industry. The company has a P/E ratio of 93.1, above the S&P 500 P/E ratio of 17.7. Shares are up 11.4% year to date as of the close of trading on Friday. Currently there are 7 analysts that rate Health Care REIT a buy, 2 analysts rate it a sell, and 9 rate it a hold. TheStreet Ratings rates Health Care REIT as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, good cash flow from operations and compelling growth in net income. However, as a counter to these strengths, we also find weaknesses including disappointing return on equity and poor profit margins. Get the full Health Care REIT Ratings Report now. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.


text:
How To Establish An Effective Good Clinical Practice in Drugs and Medical Devices
Product ID: 702252
- Duration: 90 Min
Customer Care
Fax: +1-650-565-8542
Email: email@example.com
This 90-minute webinar will help you establish an effective Good Clinical Practice (GCP) by providing a current, accurate and complete (CAC) review and understanding of the relevant and applicable regulations for clinical trials or studies, the requirements and compliance in a systematic, integrative (SI) manner.
Why Should You Attend:
To be able to achieve sustainability and to remain sustainable and competitive in global medical product markets, it is necessary to streamline regulatory compliance processes, in particular, the Good Clinical Practice (GCP) for clinical trials and studies and beyond. To establish and maintain GCP, it is critical to accurately define, document and implement "current, accurate, and complete" (CAC) requirements pursuant to the relevant and applicable laws and regulations, GCP requirements, and compliance in a systematic, integrative (SI) manner.
This webinar is intended to help you establish an effective Good Clinical Practice (GCP) by providing a current, accurate and complete (CAC) review and understanding of the relevant and applicable regulations for clinical trials or studies, the requirements and compliance in a systematic, integrative (SI) manner, all of which are regulated by the United States Food and Drug Administration (FDA). At the end of this webinar, you will leave empowered with the knowledge of applicable FDA regulations and requirements.
Areas Covered in the Seminar:
- Current, accurate, and complete (CAC) review of FDA regulations including INDs and IDEs.
- Systematic and integrative (SI) analysis of regulations and law governing clinical trials and studies, requirements, and compliance.
- General information for clinical studies.
- Clinical investigators (CI).
- Institutional review boards (IRBs).
- Sponsors.
- Monitors.
- Contract research organizations (CROs).
- ICH-GCP guidelines.
- Enforcement actions (case studies).
Who will Benefit:
This webinar will be valuable for anyone in global medical industry including, but not limited to, those working on drugs, biologics, medical devices, and in vitro diagnostic devices who are involved in the processes of clinical trials and studies, adverse event reporting, complaint handling and regulatory compliance. By understanding Good Clinical Practice (GCP) for the clinical trials and studies in a systematic, integrative manner, the process owners can better establish and maintain the compliant processes, improving patient rights, safety, wellfare and further achieving regulatory compliance.
The following employees who will benefit include:
- Clinical affairs (associates, specialists, coordinators, managers, directors and VPs)
- Complaint handling personnel
- Regulatory affairs (associates, specialists, managers, and directors)
- Quality assurance, quality control, and quality systems (associates, specialists, engineers, managers, directors and VPs)
- Research and development (associates, scientists, managers, directors and VPs)
- Product and development (associates, scientists, managers, directors and VPs)
- Marketing (associates, specialists, managers, directors and VPs)
- Site managers, and consultants.
- Contract manufacturing organization (associates, scientists, managers, directors and VPs)
- Contract research organization (associates, scientists, managers, directors and VPs)
- Senior and executive management (VPs, SVPs, Presidents and CEOs)
- Contractors and subcontractors
Dr. David Lim, obtained his Ph.D. in biological sciences at the University of Missouri-Columbia and published his thesis research in the prestigious journal "Science." Since then, Dr. Lim has held various positions at Duke, US National Laboratories, Intrexon Corporation, Terumo, US FDA/CDRH, and EraGen Biosciences, Inc., A Luminex Company. In 2009, Dr. Lim served as a panel member during the FDA's Transparency Public Meeting. Prior to founding his own consulting firm (www.RegulatoryDoctor.com/davidlim), Dr. Lim was Senior Vice President of Scientific and Regulatory Affairs at Aquavit Pharmaceuticals, Inc. in New York, wherein Dr. Lim provided inspiring and actionable solutions for sustainable business operation. Dr. Lim as Regulatory Doctor provides practical, actionable and strategic solutions integrated with emotional intelligence (EQ) skills for all aspects of global regulatory, quality, clinical and compliance matters. Over the years, Dr. Lim has analyzed over 1,000 FDA warning letters. Dr. Lim has also attended more than 50 FDA Advisory Panel Meetings and analyzed the subject matters and decision-making processes in detail. Dr. Lim is familiar with more than 200 medical products (medical devices including IVD products, biologics, drugs and combination products). Dr. Lim is a certified professional for regulatory affairs (RAC) and also is a certified quality auditor (CQA) by the American Society for Quality (ASQ). Dr. Lim is an auditor, regulatory coach, consultant and instructor for global matters pertaining to regulatory affairs, regulatory compliance, quality and clinical affairs. Currently, Dr. Lim is serving as a faculty at the Regulatory Affairs Professional Society (RAPS) and is an advisor to the Presidents and CEOs of FDA-regulated industry.
More Trainings by Expert
A Comprehensive Overview of 510(K) submission
3-hr Virtual Seminar: Medical Device Regulations and Law in the US, EU and Canada
3-hr Virtual Seminar- Medical Device Adverse Event Reporting and Vigilance System During Clinical Trials and Post-Marketing: US, EU, and Canada
Best Practices for Medical Device Reporting (MDR), Recall, Reports of Corrections and Removals
cGMPs for Medical Devices, Including In Vitro Diagnostic Devices
Refund Policy
Registrants may cancel up to two working days prior to the course start date and will receive a letter of credit to be used towards a future course up to one year from date of issuance. ComplianceOnline would process/provide refund if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange.
Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs. Substitutions can happen any time.
If you have any concern about the content of the webinar and not satisfied please contact us at below email or by call mentioning your feedback for resolution of the matter.
We respect feedback/opinions of our customers which enables us to improve our products and services. To contact us please email firstname.lastname@example.com call +1-888-717-2436 (Toll Free).
Product Reviews
This product hasn't received any reviews yet. Be the first to review this product! Write review
Pharmaceutical Compressed Air - Quality GMP Standards and RequirementsBy: Roger Cowan
Price: $249
How to Conduct a HIPAA Risk AssessmentBy: Brian Tuttle
Price: $249
Building a Vendor Qualification Program for FDA Regulated IndustriesBy: Jonathan M Lewis
Price: $249
FDA Regulations for Marketing OTC Drugs in the U.S.By: Norma Skolnik
Price: $249
Effective Annual U.S. FDA CGMP TrainingBy: John E Lincoln
Price: $249
CDISC Mapping 1: Specifications and FDA RequirementsBy: Sunil Gupta
Price: $249
Extractables and Leachables in Early Phase DevelopmentBy: Wayland Rushing
Price: $279
Veterinary Medicine and the DEA Due Diligence Requirement for Dispensing and Prescribing...By: Carlos Aquinos
Price: $229
1099 & W-9 Update - Complying with IRS Information Reporting GuidelinesBy: Miles Hutchinson
Price: $149
OSHA Recordkeeping for 2015: Beyond the OSHA 300 SummaryBy: David A. Casavant
Price: $149
Form I-9 and E-Verify, getting and staying compliantBy: Cathleen Hampton
Price: $149
Affordable Care Act Updates: What Employers need to do to PrepareBy: Vanessa G Nelson
Price: $149
Child Support: What Payroll Doesn't Know Can Hurt YouBy: Vicki M. Lambert
Price: $229
Detecting and Preventing Embezzlement in Your OrganizationBy: Peter Goldmann
Price: $249
What Employers Need to Know About Severance AgreementsBy: Janette Levey Frisch
Price: $229
FDA's Regulation of Regenerative Medicine including Stem Cell Treatments, Tissue...
Newark, NJ | Oct 19-20, 2017
FDA's New Import Program for 2017 - Strict Precision: 2-Day In-Person Seminar by Ex-FDA Official
Philadelphia, PA | Aug 24-25, 2017
Navigating the Maze for Post-Market Compliance -- Complaint Handling, MDRs, Recalls...
Minneapolis, MN | Oct 19-20, 2017
21 CFR Part 11 Compliance for SaaS/Cloud Applications: 2-day In-person Seminar
Philadelphia, PA | Sep 14-15, 2017
Quality Control Laboratory Compliance - cGMPs and GLPs: One and a Half-day In-person Seminar
San Francisco, CA | Nov 9-10, 2017
Effective Quality Oversight of Pharmaceutical Contract Manufacturing Organizati...
Newark, NJ | Sep 21-22, 2017
Latin America: Regulatory Compliance Requirements for Life Science Products...
Philadelphia, PA | Aug 24-25, 2017
Computer System Validation - Reduce Costs and Avoid 483s: 2-Day In-Person Seminar
Philadelphia, PA | Sep 14-15, 2017
Complete 1099, TIN Matching, B-Notice, FATCA and Nonresident Alien 1042-S Compl...
Dallas, TX | Sep 7-8, 2017
Ensuring Compliance with Advertising and Promotional Requirements for Drugs and...
Boston, MA | Nov 9-10, 2017
Managing Your FDA Inspection: Before, During and After: 2-Day In-Person Seminar by Ex-FDA Official
Boston, MA | Oct 17-18, 2017
ACH Risk Management: 2-day Workshop
San Diego, CA | Nov 2-3, 2017
Metrics & Predictive Analytics in Human Resources-Reducing Risk and Improving...
Washington, DC | Sep 14-15, 2017
Designing and Sustaining New and Existing Product Stability Testing Program
San Diego, CA | Sep 4-5, 2017
Managing an Effective AML Compliance Program: 2-day In-Person Seminar
Phoenix, AZ | Dec 7-8, 2017
General requirements for the competence of testing and calibration laboratoriesProvider: ANSI
Price: $142
IEC 62304:2015 ''Medical Device Software - Software Life Cycle Processes''Provider: SEPT
Price: $299
IEC 62304:2015 ''Medical Device Software - Software Life Cycle Processes''Provider: SEPT
Price: $149
ISO 13485 Procedure 754-Customer PropertyProvider: 13485 Store
Price: $12
Measurement management systems - Requirements for measurement processes and measuring equipmentProvider: ANSI
Price: $120
Geometrical Product Specifications (GPS) - Geometrical tolerancing - Tolerances of form, orientation...Provider: ANSI
Price: $250
Templates and Plans for Software Configuration Management Documents-Version 6.0Provider: SEPT
Price: $299
Computer System Validation Master PlanProvider: LabCompliance
Price: $90
Zero Acceptance Number Sampling Plan for Receiving, In-Process and Final InspectionProvider: Quality-Control-Plan
Price: $37
Standard Operating Procedure: FDA InspectionsProvider: LabCompliance
Price: $49
AS9003 Comprehensive Quality System Kit for Inspection and Test Quality Control SystemProvider: At-PQC
Price: $397
ISO 13485 and FDA Compliant Internal Audit Tools: Checklist, Procedure and FormsProvider: 13485 Store
Price: $95
Template for a Software Maintenance Plan - Fourth EditionProvider: SEPT
Price: $99
Sarbanes Oxley Treasury Risks and ControlsProvider: Audit Net
Price: $50
ISO 13485 Gap ChecklistProvider: 13485 Store
Price: $59


text:
PrimaLoft® Comfort Pillow
Enter your Email Address and click 'Continue' Example: email@example.com Submit Cancel Forgot Password Close /GarnetHill/US/Global/Popups/forgot_password Enter your email address
10 0
false pdp {"scheme":"product1_cr"}
false pdp {"scheme":"product2_cr"}
Primaloft® Comfort Pillow is rated out of 5 by 234.
Rated 5 out of 5 by IslandInk from Favorite Pillows These are our favorite pillows. We're both side-sleepers, and these are the most comfortable we've ever found.
Date published: 2017-08-03
Rated 5 out of 5 by Techy from Comfortable pillow I actually purchased this pillow for my sister, and she just loves it! She is a side sleeper and says that it's very comfortable! I have purchased a couple for my other sister too, and she is also in love with them! I have used this pillow for a few years now and would not use a different brand. They are wonderful! I use to have alot of neck pain, but no more!
Date published: 2017-07-27
Rated 5 out of 5 by LadyDi44 from Best Pillows Ever This is my 2nd set of these pillows and being a side sleeper, they are perfect for me. I use GH pillow protectors and sheets and both the protectors and cases snug the pillow in for extra support. Great pillows at a great price - 25% off! I highly recommend them for anyone who wants to sleep like a baby!
Date published: 2017-05-25
Rated 5 out of 5 by Shophop from Superb pillow I'm a side sleeper with neck, shoulder and back issues and have purchased several pillows that claimed to ease pain and provide support and proper alignment. None worked. This garnet hill pillow is the best one I've ever owned and has oven me tremendous relief. I'm ordering one for every bed in my home.
Date published: 2017-05-15
Rated 5 out of 5 by Lanes from another great product from garnet hill! I love your bedding basics.
Date published: 2016-12-27
Rated 5 out of 5 by Antiquelady from Very comfortable and great quality. Always like quality of products.
Date published: 2016-12-23
Could these pillows be classified as EXTRA FIRM? [My husband and I both require the FIRMNESS feature.]
I would'nt consider this pillow extra firm. It's rather soft but holds that set softness and goes no further.
Date published: 2013-10-22
Do the standard size pillowcases you sell fit on the queen size pillow?
They just go to the end of the pillow. If you want ANY fabric folding nicely down the side of the pillow you won't get it!
Date published: 2014-12-28
Are these pillows treated with any flame-retardant chemicals?
These pillows are not treated with any flame retardant chemicals.
Date published: 2016-01-20
Do these pillows help with temperature regulation? We are such hot sleepers and could really use a pillow that helps with that.
These pillows do not regulate temperature.
Date published: 2017-01-19
Which pillow is firmer/more supportive - the luxury or the comfort?
The Primaloft Luxury pillow is slightly more firm than the Primaloft Comfort Pillow.
Date published: 2016-01-11
Product:14756-PrimaLoft® Comfort Pillow


text:
Zynga Loves its Allen & Co. CFO, IPO Documents Show
- 3586 views
Zynga Chief Financil Officer David M. Wehner, a former managing director at investment banking firm Allen & Co., earned almost $18 million during 2010, documents show. The compensation consists of salary, bonuses and stock awards assigned to Wehner after he began working full time at the casual game maker in June.
Wehner's package puts him near the top of the
Zynga tapped Allen & Co. to help underwrite its initial public offering, along with BofA Merrill Lynch, Barclays Capital, Goldman Sachs and J.P. Morgan.
Wehner replaced Mark Vranesh, who became the casual game maker's chief
By way of comparison, LinkedIn CFO, Steven Sordello, took home $342,507 during 2010. He owned just north of 1 million shares prior to the LinkedIn IPO, thanks in part to four years of service to the company. Those shares would be worth more than $95 million if they were sold today.
Alexander Haislip is the author of Essentials of Venture Capital
Related: Viacom, Occidental Petroleum and Apple Top CFO Pay Report
LinkedIn, Pandora, Groupon and Zynga are Giving Startups Hope and Acquirers Cold Feet
Browse our extensive library of free white papers focused on the latest financial, technology and business issues.


text:
Last Month at the Federal Circuit - March 2003
Judges: Clevenger (author), Mayer, and Rader
In Boehringer Ingelheim Vetmedica, Inc. v. Schering-Plough Corp., No. 02-1026 (Fed. Cir. Feb. 21, 2003), the Federal Circuit affirmed the district court's judgment that U.S. Patent No. 5,476,778 ("the '778 patent") is infringed and not invalid. The PTO issued Boehringer Ingelheim Vetmedica, Inc. ("Boehringer") the '778 patent for methods of growing, isolating, and attenuating the virus responsible for Porcine Reproductive Respiratory Syndrome ("PRRS") after Boehringer discovered a simian (monkey) cell line could be used successfully as a host. Boehringer filed suit against Schering- Plough Corporation and Schering Corporation (collectively "Schering"), alleging that Schering's vaccine virus, which is grown on a similar simian cell line, infringed the method claimed by Boehringer's '778 patent. The district court denied Boehringer's motion for a preliminary injunction when Boehringer was unable to show that Schering's obviousness challenge lacked substantial merit or that irreparable harm would result. Following the denial of various motions for SJ, the district court considered Schering's inequitable-conduct defense separately and held no inequitable conduct during prosecution of the '778 patent. At trial, the jury found that Schering had infringed the '778 patent by equivalence and that the patent was not obvious and, therefore, not invalid. The district court denied Schering's motions for JMOL or new trial and entered judgment for Boehringer. Schering appealed the denial of its motion for JMOL, asserting that the district court had incorrectly construed the claims and the jury's verdict was not supported by substantial evidence. Boehringer cross-appealed, asserting an erroneous claim construction. The Federal Circuit reviewed the interpretation of the term "isolating" in the context of the preamble claim language: "A method of growing and isolating swine infertility and respiratory syndrome virus, ATCC-VR2332, which comprises inoculating the virus on a full or partial sheet of simian cells . . . ." The Court noted that preamble language will limit the claim if it recites not merely a context to which the invention may be used, but the essence of the invention, without which performance of the recited steps is nothing but an academic exercise. In other words, the PRRS virus is "isolated" each time the virus is propagated into a fresh tissue culture bottle, not just when the virus is initially isolated from an infected pig. The Court concluded that the district court had properly recognized "isolating" as part of the definition of the claimed subject matter and was, therefore, a limitation of the claim. The Federal Circuit disagreed with the district court's construction that the claim language "until . . . CPE is observed" means "until there is a significant degree of CPE" (cytopathic effect). Rather, the Federal Circuit held that the limitation merely defines the minimum period for incubation of the inoculated cell sheet. Given the infringement analysis, however, this difference in construction was considered harmless error. Concerning the finding of infringement, the Federal Circuit agreed that Schering's VR2525 strain is equivalent to the claimed strain. Schering argued for no equivalence because, when administered to a pig, its virus will generate a protective immune response to PRRS, while a pig inoculated with Boehringer's virus develops PRRS. According to Schering, this effect underscored differences in function, way, or result and precluded a finding of insubstantial differences between the strains. The Federal Circuit concluded, however, that what happens when the virus is administered to a pig is irrelevant to the assessment of whether the two viral strains are equivalent in the in vitro culture method defined by the claim. Therefore, the Federal Circuit agreed that substantial evidence supported the jury's verdict of equivalence.The second issue of equivalence concerned the phrase "until . . . CPE is observed." The Federal Circuit relied upon expert testimony that Schering's practice of incubating a viral culture for a defined period of time performs the same function, way, and result to support the jury's verdict of equivalence. Finally, the Federal Circuit agreed with the district court's analysis of the obviousness issue. Noting that a showing of obviousness requires a motivation or suggestion to combine or modify prior art references, coupled with a reasonable expectation of success, the Court concluded that the jury was entitled to conclude that such a showing had not been made. In particular, the Court pointed to references reporting failure of attempts to isolate PRRS viruses with monkey-kidney cells, thus negating an expectation of success.


text:
We help you search for a Ossett double bass tutor. Double Bass lessons are a great method to start an entertaining new hobby, acquire a new talent and gain confidence with double bass. Use our service to search for Ossett double bass teachers and choose which suits your needs so you can enjoy your double bass tuition in Ossett today!
First Tutors: Music is the fastest way to discover Ossett double bass teachers in the UK, helping you find Ossett double bass tuition close to home and Ossett teachers to assist with any instrument, for example, piano, violin or guitar. We can help you find Ossett double bass lessons or a one-to-one Ossett double bass tutor to prepare for double bass grades and develop your double bass skills! Our search will order Ossett double bass tutors in your area according to their lesson charges and distance from you.
If you are a double bass tutor wishing to offer double bass tuition services in Ossett or throughout the UK, please register with First Tutors: Music or learn about us here. Becoming a Ossett double bass tutor is a brilliant way to improve your own knowledge through providing double bass lessons while assisting others, all in the Ossett area!


text:
Argentina dairy sector continues its recovery from the 2009/10 drought and breaking production records. Argentine milk production for CY2012 is projected at 12.45 million metric tons (MMT); a new record high, the result of very good weather during 2011 and in anticipation of relatively strong farmgate prices.
THIS REPORT CONTAINS ASSESSMENTS OF COMMODITY AND TRADE ISSUES MADE BY USDA STAFF AND NOT NECESSARILY STATEMENTS OF OFFICIAL U.S. GOVERNMENT POLICY Required Report - public distribution Date: 11/8/2011 GAIN Report Number: Argentina Dairy and Products Annual Argentina Dairy and Products Annual Report Approved By: Melinda D. Sallyards Prepared By: Kenneth Joseph & Andrea Yankelevich Report Highlights: Argentina dairy sector continues its recovery from the 2009/10 drought and breaking production records. Argentine milk production for CY2012 is projected at 12.45 million metric tons (MMT); a new record high, the result of very good weather during 2011 and in anticipation of relatively strong farmgate prices. Total dairy exports are expected to grow significantly in response to the increase in milk production. Whole Milk Powder (WMP) is by far Argentina?s number one dairy export product. Commodities: Dairy, Cheese Dairy, Dry Whole Milk Powder Dairy, Milk, Fluid Dairy, Milk, Nonfat Dry Production: Post forecasts milk production for 2012 to reach a new record high of 12.45 MMT - equivalent to 12.09 billion liters. 2011 milk production is estimated at 11.99 MMT ? a revised increase of 920,000 MT over the previous forecast. This is due to the excellent weather conditions during the period Jan ? Sept 2011, abundant and high quality feed, and high farmgate prices. Milk production in 2012 is forecast to increase further but at a slower pace due to expected inflation that would lower returns. Most existing producers are expanding their operations; at the farm level dairymen are purchasing new equipment, improving nutrition, and using higher quality genetics which is mostly purchased in the United States. The current cost of feed encourages farmers to produce more milk (approximately 2.5 kg corn to produce one liter of milk). Despite the huge increase in production in 2011 (almost 13 percent increase compared to 2010) there are no new producers expected to come into the sector, mainly due to the significant capital investment required. Some of the smaller inefficient producers are switching over to soybean production. Current returns on soybeans are significantly lower compared to dairy, but crop production demands less investment and management. One of the biggest problems the Argentine dairy industry currently faces is labor. Costs due to salary agreements at the processing plants are continuously increasing and it is becoming more and more difficult to retain personnel at the farm. Currently, Argentina has approximately 2,15 million head in the dairy herd composed mostly of Holstein cows, and distributed mainly in the central region. The increase over 2010 follows a drought period in 2009/2010 when 30 percent of the calves died. Contacts estimate that due to the high margins, the dairy herd will grow up to 2,2 million head in 2012. The processing sector is dominated by 6 or 7 large firms that process about 60 percent of the total production. There are two big investments projected to be operational in 2013. One is a dry milk plant that will process 500,000 liters per day, and the other one is a dry whey plant that will free up capacity of 1 million liters a day of WDP production. Whole Milk Powder (WMP) production is expected to increase in 2012 to 330,000 tons. Most of the surplus milk produced in 2011 and 2012 will be processed into Whole Milk Powder, which will then be exported. The big increase in WMP production is the result of the surplus in fluid milk that occurred in 2011. The industry?s current processing capacity is approximately 14 million liters per day, running at full capacity during the spring. Cheese production is forecast to grow in 2012 to 575,000 tons, a small increase from 2011. Approximately 40 percent of total milk production will be processed into cheese, mostly soft and semi soft varieties. Some of the additional milk produced this year will also be processed into cheese. Consumption: Domestic consumption is forecast to expand moderately in 2012. The slight increase in consumption is linked to the increase in population (estimated at 40 million as per the 2010 National Census) and the introduction of new products. Argentina is among the largest per capita consumers of milk in the world at 210 liters per capita. Argentines consume the most cheese out of any dairy product. Post forecast this trend to remain the same. To stimulate consumption, the industry continuously introduces in the market new products, such as yogurts or milk with nutritional additives, and bio-engineered products. The average level of milkfat and skim solids content is 3.5 percent fat, 3.4 percent protein and 5 percent lactose. Trade: Exports Total exports of dairy products are expected to increase significantly in response to the anticipated increase in milk production. Most of the milk production surplus will be exported as WMP, given the limited opportunities for expanding sales in the domestic market. Argentina exports about 20 percent of its total milk production, mostly as WMP and cheese in second place. Contacts foresee that markets for Argentine exports will remain the same. Argentina exports mainly to Brazil, Venezuela and Algeria, followed by China and Chile. Argentina exports to Brazil under a bilateral MERCOSUR agreement. The agreement has been renewed and will be valid until November 2012, and Brazil has increased the monthly import quota of 3,600 MT for WMP. There is an agreement signed with Venezuela that sets an import quota of 6,315 MT under a preference system. According to contacts, Argentina?s exporting efforts are now geared to maintain current markets opened and also towards increasing exports to China and the Asian countries. WMP exports: is the top dairy product exported. The main markets are Venezuela, Algeria and Brazil for WMP and Brazil, Philippines and Chile for Nonfat Dry Milk. The total exports for the period of Jan ? Aug 2011 totaled US$ 473 million (equivalent to 112,122 MT). Cheese exports: The export market has the potential for growth but there are a limited number of companies with the expertise to export. The industry prefers to process excess milk output into WMP, and most of the cheese production is for domestic consumption. The types of cheeses currently exported are mainly hard and semi-hard, Individually Quick Frozen (IQF) and grated. Main markets for Argentine cheese are Brazil, Chile and the Russian Federation. Imports Argentine imports of dairy products are negligible. In 2011 Argentina imported mainly caseinates and casein derivatives from Denmark and the Netherlands. No big changes are expected in 2012. Stocks: Stocks of dairy products are estimated to be higher in 2011 and 2012 due to the significant growth in production. Policy: With the recent re-election of current President Cristina Fernandez de Kirchner, no major changes in the government?s policy are expected. The government controls dairy prices to guarantee the domestic market is well supplied and price increases are moderate. However large dairy processors have been authorized to increase prices for those products considered not essential, such as yogurt and cheese. The system implemented for retail price control is structured in 3 segments: Basic (massive products, includes milk), selective, and premium. The government allows maximum price increases for each segment. Exporters indicate that export permits are easy to obtain, there are no export taxes and no maximum export prices. Marketing: Farmgate prices remain relatively strong but margins are lower than in 2010 due to increased production costs. Costs are expected to continue to increase in 2012, partially due to increasing labor costs and high inflation. According to private sources, retail prices for dairy products have increased 38.5 percent during Jan- Sep 2011, while producers received an increase of 4.93 percent for their milk price during the same period (farmgate price per liter AR$ 1.42 in January and AR$ 1.49 in September). These increases in retail prices are observed even with the surplus milk production of the first 8 months of 2011. Production, Supply and Demand Data Statistics: Dairy, Milk, Fluid A 2010 2011 2012 rgentina Market Year Begin: Jan Market Year Begin: Jan Market Year Begin: Jan 2010 2011 2012 USDA USDA O New Post fficial O N USDA ew Post fficial O New Post fficial Cows In Milk 2,100 2,100 2,100 2,150 2,200 Cows Milk Production 10,600 10,600 11,070 11,990 12,450 Other Milk Production 0 0 0 0 0 Total Production 10,600 10,600 11,070 11,990 12,450 Other Imports 0 0 0 0 0 Total Imports 0 0 0 0 0 Total Supply 10,600 10,600 11,070 11,990 12,450 Other Exports 22 18 25 16 18 Total Exports 22 18 25 16 18 Fluid Use Dom. Consum. 2,130 2,140 2,160 2,180 2,225 Factory Use Consum. 8,448 8,442 8,885 9,794 10,207 Feed Use Dom. Consum. 0 0 0 0 0 Total Dom. Consumption 10,578 10,582 11,045 11,974 12,432 Total Distribution 10,600 10,600 11,070 11,990 12,450 Dairy, Milk, Nonfat Dry A 2010 2011 2012 rgentina Market Year Begin: Jan Market Year Begin: Jan Market Year Begin: Jan 2010 2011 2012 USDA New USDA New USDA New Official Post Official Post Official Post Beginning Stocks 10 10 10 7 9 Production 38 35 37 50 55 Other Imports 0 0 0 0 0 Total Imports 0 0 0 0 0 Total Supply 48 45 47 57 64 Other Exports 20 20 19 28 33 Total Exports 20 20 19 28 33 Human Dom. Consumption 18 18 18 20 21 Other Use, Losses 0 0 0 0 0 Total Dom. Consumption 18 18 18 20 21 Total Use 38 38 37 48 54 Ending Stocks 10 7 10 9 10 Total Distribution 48 45 47 57 64 Dairy, Dry Whole Milk Powder A 2010 2011 2012 rgentina Market Year Begin: Jan Market Year Begin: Jan Market Year Begin: Jan 2010 2011 2012 USDA New USDA New USDA New Official Post Official Post Official Post Beginning Stocks 20 20 17 27 40 Production 220 210 260 315 330 Other Imports 2 0 1 0 0 Total Imports 2 0 1 0 0 Total Supply 242 230 278 342 370 Other Exports 170 128 200 222 250 Total Exports 170 128 200 222 250 Human Dom. Consumption 55 75 58 80 80 Other Use, Losses 0 0 0 0 0 Total Dom. Consumption 55 75 58 80 80 Total Use 225 203 258 302 330 Ending Stocks 17 27 20 40 40 Total Distribution 242 230 278 342 370 Dairy, Cheese Argentina 2010 2011 2012 Market Year Begin: Jan Market Year Begin: Jan Market Year Begin: Jan 2010 2011 2012 USDA New USDA New USDA New Official Post Official Post Official Post Beginning Stocks 29 29 28 37 40 Production 540 540 555 555 575 Other Imports 4 3 4 3 3 Total Imports 4 3 4 3 3 Total Supply 573 572 587 595 618 Other Exports 45 45 55 50 55 Total Exports 45 45 55 50 55 Human Dom. Consumption 500 490 505 505 523 Other Use, Losses 0 0 0 0 0 Total Dom. Consumption 500 490 505 505 523 Total Use 545 535 560 555 578 Ending Stocks 28 37 27 40 40 Total Distribution 573 572 587 595 618


text:
You must register to post or download hacks.
If you are having any issues, shoot us an email, Contact MPGH Support.
As always, have fun and enjoy your stay!
- MPGH Staff
Jk, Im just here to check out the forum and see what I can contribute.
Ay, Welcome and have fun!
ravioli ravioli mpgh's a fucking faggotoli
Welcome to MPGH! Enjoy your time here.
» Vᴇʀɪғɪᴇᴅ ﹢ Tʀᴜsᴛᴇᴅ GTAV﹣O Cᴀsʜ Dʀᴏᴘ Sᴇʀᴠɪᴄᴇ «
Dɪᴅ I ʜᴇʟᴘ ʏᴏᴜ ɪɴ ᴀɴʏᴡᴀʏ﹖ Iғ sᴏ﹐ ᴘʟᴇᴀsᴇ ᴘʀᴇss ᴇɪᴛʜᴇʀ ᴛʜᴇ ᴏʀ ᴛʜᴇ .


text:
Mille Bornes Tintin Gameplay 1 iOS / Android
Mille Bornes Tintin
By: Dujardin
Genre: Board
Video Tips
Let's play Mille Bornes Tintin! This is part 1 of my walkthrough guide for the iOS game, Mille Bornes Tintin by Dujardin Sas.
I will update this post with more tips and tricks, so please bookmark this page and keep on checking in!
If you have any questions, feel free to ask for extra help in the comments section.
Hit like if this helped you!
Visit Mille Bornes Tintin walkthrough page for level videos, tutorials, cheats and more.
Gameplay Questions
Questions related to gameplay of Mille Bornes Tintin iPhone game.


text:
Stuffed Mushrooms - Vegan Friendly
Recipe by One Happy Woman
These are delicious and no one was more surprised than I was, the confirmed carnivore—they satisfy that fifth 'umami' taste for savory, protein-rich foods. They are easy to make and, frankly, better than a lot of recipes I have that involve meat (!) This is an adaptation of a recipe I found online. It's vegan-friendly but also appeals to omnivores. If you want to jump-shift to vegetarian, top them with parmesan cheese rather than the nutritional yeast. These may be made up to 24 hours ahead.
Ingredients Nutrition
- 24 brown button mushrooms
- 3 tablespoons olive oil
- 1⁄2 onion
- 1 stalk celery
- 3 garlic cloves
- 2 -3 tablespoons breadcrumbs
- 1⁄2 cup walnuts
- 1⁄2 cup tempeh or 1⁄2 cup tofu
- 1⁄2 cup vegetable broth
- 1⁄4 cup nutritional yeast
- salt or soy sauce
- 1 teaspoon lemon pepper
- 1 tablespoon dried parsley flakes
- 1 teaspoon poultry seasoning
Directions See How It's Made
- Remove the stems from the mushroom caps and chop them, along with the onions and celery.
- Put the garlic through a press and saute the garlic with the chopped vegetables.
- Chop the walnuts.
- Add the rest of the ingredients and pulse in a food processor.
- Adjust the texture with broth or breadcrumbs.
- Place the mushroom caps on a greased baking pan and sprinkle with salt.
- Stuff the caps and top with a sprinkle of nutritional yeast (or the Parmesan, if you're going vegetarian).
- Bake, uncovered at 350 for 30 minutes if at room temperature, 40, if chilled.


text:
Claire - 1-2-year-old Bully/Pointer mix. She is a very nice girl who is loving and well-behaved. She loves people and listens well. She is good with other dogs.
Visit us at the Gainesville Petsmart on Archer Rd Saturdays 11 am to 5 pm and Sundays Noon to 5 pm. Be sure to visit our web page: http://www.puppyhillfarm.com for more information about us and for any updates, and our Facebook page at http://www.facebook.com/puppyhillfarm
We adopt dogs and cats of all ages to good homes at the Gainesville Petsmart (Butler Plaza on Archer Rd, click for a map) every Saturday and Sunday. We have a great selection of adoptable animals, including puppies, adult dogs, small dogs, cats, and kittens. All of our animals have been started on vaccinations (depending on how long they have been with us, they may need further vaccinations after adoptions). All have been vet checked and treated for any notable illness. All dogs are heartworm negative and many have been through heartworm treatment in our program. Some of these animals may have special needs, all of which are discussed at time of adoption.
We often have specials on adult animal adoptions. Not that these animals have flaws, but they are slightly used and may not be perfect! These are adult animals looking for a permanent home and they have many different stories of their pasts and all deserve a second chance at the good life.
Thank You!
Your message has been sent to Puppy Hill Farm.
You'll receive a copy, too, at to help you keep track of which pets you've inquired about, and which shelters and rescues you've emailed.
NOTE: Some shelters have physical locations you can visit; some of these shelters may only have pets for a limited time, so please do not wait for a reply—just go visit the shelter! Other organizations are rescue groups run by busy volunteers who may take a while to reply. You can find information about the shelter or rescue group caring for this pet, and their adoption procedures, on the pet's details page on Adopt-a-Pet.com.


text:
Brand New C.F.Martin D-28 Authentic 1937. New w/ Warranty (We are an Authorized C.F.Martin Dealer).Perhaps the most revered vintage D-28s are the ones created in 1937 with forward shifted hand-scalloped X-bracing, Adirondack red spruce soundboard and a 1 3/4" neck width. This addition to the Authentic series is a recreation of the original 1937 model offered with Madagascar rosewood back and sides.
Model: D-28 Authentic 1937
Construction: Mahogany Blocks/Dovetail Neck Joint - Hide Glue
Body Size: D-14 Fret
Top: Solid Adirondack Spruce
Rosette: Style 28
Top Bracing Pattern: Standard ''X'' Scalloped (Authentic Style) Circa 1937 - Forward Shifted
Top Braces: Solid Adirondack Spruce 5/16''
Back Material: Solid Madagascar Rosewood
Back Purfling: 28 Style Zig-Zag (Authentic)
Side Material: Solid Madagascar Rosewood
Endpiece: Grained Ivoroid in a Narrow 1937 Shape
Endpiece Inlay: Black/White Boltaron
Binding: Grained Ivoroid
Top Inlay Style: Bold Herringbone
Side Inlay: none
Back Inlay: Black/White Boltaron
Neck Material: Solid Genuine Mahogany
Neck Shape: Authentic 1937 Barrel & Heel
Nut Material: Bone
Headstock: Solid/Diamond/1937 Taper
Headplate: Solid Madagascar Rosewood
Heelcap: Grained Ivoroid
Fingerboard Material: Solid Black Ebony
Scale Length: 25.4''
Number Of Frets Clear: 14
Number Of Frets Total: 20
Fingerboard Width At Nut: 1-3/4''
Fingerboard Width At 12th Fret: 2-1/4''
Fingerboard Position Inlays: Diamonds & Squares - Long Pattern 1937
Fingerboard Binding: none
Finish Back & Sides: Polished Gloss w/ Aging Toner
Finish Top: Polished Gloss w/ Aging Toner
Finish Neck: Polished Gloss w/ Aging Toner
Bridge Material: Solid Black Ebony
Bridge Style: Authentic Style Belly w/ Long Saddle
Bridge String Spacing: 2-5/16''
Saddle: 16'' Radius/Long Bone
Tuning Machines: Waverly Nickel w/ Butterbean Knobs
Recommended Strings: Martin SP Lifespan Phosphor Bronze Medium Gauge (MSP7200)
Bridge & End Pins: Ivory Colored Poly w/ Black Dots
Pickguard: Delmar Tortoise Color
Case: 545V Harptone
Interior Label: none
Electronics: none
|2014 (1937 reissue)
|Brand New
|Original Hard
Payment: rainbowmusic.com accepts Visa, Mastercard, Certified Check, Money Order, Wire Transfer Accepted (and of course CASH!) 24 hour approval period on all guitars ( excluding consignments). Please submit the correct billing address for the credit card to help us prevent fraud. If an incorrect billing address is submitted we will refuse shipment. Sales Tax: There is a 6.00% sales tax charge for any order delivered within Pennsylvania
Shipping and Insurance to be determined at time of order and we do keep a want file. We usually ship Via FedEX or UPS, All Amps & FX are in good working order (unless noted) and sold AS-IS
POLICY SUMMARY: Please call during Business Hours for an accurate in-hand description or to order an instrument. We offer 24-hour approval on all of our guitars for authenticity ONLY. This includes all parts and instrument finish. We DO NOT offer approval for "tone" or other personal preferences. We simply offer the most original and most collectable vintage and rare guitars around at reasonable prices. All prices reflect a 3% cash discount. International buyers: Please contact us for exact shipping quotes. All VAT, Local and/or Customs taxes are the sole responsibility of the buyer. Due to shipping length and Customs operations, we cannot offer approval on guitars and amps to our overseas buyers. Many of our instruments are investment grade and of museum quality. Due to the fragile nature of certain older guitars, which are susceptible to being damaged in shipment due to handling and/or extreme weather conditions, approval may not be available on all instruments. We cannot offer an approval period for consignment guitars, guitars on layaway, or guitars discounted below our posted price. GENERAL POLICIES: A 50% Non Refundable Deposit will hold an instrument for 30 days (excluding consignments). No approval time on layaways. We accept consignments. Call for our competitive rates. As Always, "WE BUY GUITARS". ORDERS POLICY: The confirmation of an order by e-mail or any other type of electronic confirmation does not constitute rainbowmusic.com's acceptance of the order. rainbowmusic.com has the right to refuse shipment without any prior notification. All returns will be subject to a 15% restocking fee to avoid rentals/returns. Also, return authorizations will not be issued without phone contact - no emails! Guitars returned within the 24-hour approval period for authenticity will be refunded in full minus shipping, packaging, and insurance charges. The approval period starts after items have been signed for as delivered. All returns must be returned in the exact same condition and as they were shipped. Buyers must pay for prompt return shipping by UPS or Fed-Ex and must be sent fully insured for replacement value. If your return has been authorized, please note: Fed-Ex and UPS do not insure fine collectable guitars in excess of $2500. We suggest Heritage Insurance (call 1-800-289-8837) for all instrument insurance needs. They are the best in the business and are experts when it comes to insuring high value instruments. Proof of insurance is required before return authorizations will be issued. NOTE: Anything shipped to us that does not bear a valid return authorization number provided by us will not be accepted by our receiving department